Cargando…
Lipid-Lowering Effects of Inonotus obliquus Polysaccharide In Vivo and In Vitro
Excessive lipid intake will cause hyperlipidemia, fatty liver metabolism disease, and endanger people’s health. Edible fungus polysaccharide is a natural active substance for lipid lowering. In this study, the HepG2 cell model induced by oleic acid and mice model induced by a high-fat diet was estab...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700920/ https://www.ncbi.nlm.nih.gov/pubmed/34945636 http://dx.doi.org/10.3390/foods10123085 |
_version_ | 1784620874381393920 |
---|---|
author | Yang, Mo Hu, Dong Cui, Zhengying Li, Hongxuan Man, Chaoxin Jiang, Yujun |
author_facet | Yang, Mo Hu, Dong Cui, Zhengying Li, Hongxuan Man, Chaoxin Jiang, Yujun |
author_sort | Yang, Mo |
collection | PubMed |
description | Excessive lipid intake will cause hyperlipidemia, fatty liver metabolism disease, and endanger people’s health. Edible fungus polysaccharide is a natural active substance for lipid lowering. In this study, the HepG2 cell model induced by oleic acid and mice model induced by a high-fat diet was established. The lipid-lowering effects of Inonotus obliquus polysaccharide (IOP) was investigated in vivo and in vitro. Glucose (251.33 mg/g), rhamnose (11.53 mg/g), ribose (5.10 mg/g), glucuronic acid (6.30 mg/g), and galacturonic acid (2.95 mg/g) are present in IOP, at a ratio of 85.2:3.91:1.73:2.14:1. The molecular weight of IOP is 42.28 kDa. Treatment with 60 mg/L of IOP showed a significant lipid-lowering effect in HepG2 cells compared with the oleic acid-treated group. In the oil red O-stained images, the red fat droplets in the IOP-treated groups were significantly reduced. TC and TG levels of IOP-treated groups decreased. IOP can alleviate the lipid deposition in the mice liver due to high-fat diet, and significantly reduce their serum TC, TG, and LDL-C contents. IOP could activate AMPK but decrease the SREBP-1C, FAS, and ACC protein expression related to adipose synthesis in mice. IOP has a certain potential for lipid-lowering effects both in vivo and in vitro. |
format | Online Article Text |
id | pubmed-8700920 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87009202021-12-24 Lipid-Lowering Effects of Inonotus obliquus Polysaccharide In Vivo and In Vitro Yang, Mo Hu, Dong Cui, Zhengying Li, Hongxuan Man, Chaoxin Jiang, Yujun Foods Article Excessive lipid intake will cause hyperlipidemia, fatty liver metabolism disease, and endanger people’s health. Edible fungus polysaccharide is a natural active substance for lipid lowering. In this study, the HepG2 cell model induced by oleic acid and mice model induced by a high-fat diet was established. The lipid-lowering effects of Inonotus obliquus polysaccharide (IOP) was investigated in vivo and in vitro. Glucose (251.33 mg/g), rhamnose (11.53 mg/g), ribose (5.10 mg/g), glucuronic acid (6.30 mg/g), and galacturonic acid (2.95 mg/g) are present in IOP, at a ratio of 85.2:3.91:1.73:2.14:1. The molecular weight of IOP is 42.28 kDa. Treatment with 60 mg/L of IOP showed a significant lipid-lowering effect in HepG2 cells compared with the oleic acid-treated group. In the oil red O-stained images, the red fat droplets in the IOP-treated groups were significantly reduced. TC and TG levels of IOP-treated groups decreased. IOP can alleviate the lipid deposition in the mice liver due to high-fat diet, and significantly reduce their serum TC, TG, and LDL-C contents. IOP could activate AMPK but decrease the SREBP-1C, FAS, and ACC protein expression related to adipose synthesis in mice. IOP has a certain potential for lipid-lowering effects both in vivo and in vitro. MDPI 2021-12-12 /pmc/articles/PMC8700920/ /pubmed/34945636 http://dx.doi.org/10.3390/foods10123085 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Yang, Mo Hu, Dong Cui, Zhengying Li, Hongxuan Man, Chaoxin Jiang, Yujun Lipid-Lowering Effects of Inonotus obliquus Polysaccharide In Vivo and In Vitro |
title | Lipid-Lowering Effects of Inonotus obliquus Polysaccharide In Vivo and In Vitro |
title_full | Lipid-Lowering Effects of Inonotus obliquus Polysaccharide In Vivo and In Vitro |
title_fullStr | Lipid-Lowering Effects of Inonotus obliquus Polysaccharide In Vivo and In Vitro |
title_full_unstemmed | Lipid-Lowering Effects of Inonotus obliquus Polysaccharide In Vivo and In Vitro |
title_short | Lipid-Lowering Effects of Inonotus obliquus Polysaccharide In Vivo and In Vitro |
title_sort | lipid-lowering effects of inonotus obliquus polysaccharide in vivo and in vitro |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700920/ https://www.ncbi.nlm.nih.gov/pubmed/34945636 http://dx.doi.org/10.3390/foods10123085 |
work_keys_str_mv | AT yangmo lipidloweringeffectsofinonotusobliquuspolysaccharideinvivoandinvitro AT hudong lipidloweringeffectsofinonotusobliquuspolysaccharideinvivoandinvitro AT cuizhengying lipidloweringeffectsofinonotusobliquuspolysaccharideinvivoandinvitro AT lihongxuan lipidloweringeffectsofinonotusobliquuspolysaccharideinvivoandinvitro AT manchaoxin lipidloweringeffectsofinonotusobliquuspolysaccharideinvivoandinvitro AT jiangyujun lipidloweringeffectsofinonotusobliquuspolysaccharideinvivoandinvitro |